2 FTSE 100 stocks I’d buy in February and 1 I’d sell

Here are some of the stocks I’m buying and selling this month.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Every investor loves dividends. They’re the bread and butter of investing. Studies have shown that if you’re not investing with dividends in mind, you stand no chance of matching the market’s returns as around 50% of these come from reinvested dividends. 

That’s why I’m always hunting out the best dividend stocks and trying to avoid the worst, those dividend stocks that are clearly pursuing an unsustainable dividend policy.

Two top dividend picks 

BP (LSE: BP) and GlaxoSmithKline (LSE: GSK) are two dividend champions that look extremely attractive right now. Shares in these two companies both offer a dividend yield of 5% or more, and as we head into 2017, the outlook for both companies is improving.

This time last year, the price of Brent crude oil was around $41 a barrel. Today, the price is more than 25% higher at $54 a barrel, which is great news for BP. Over the past year, the company has been cutting costs to deal with the low oil price environment, and over the next 12 months, these actions should begin to pay off. 

Indeed, during 2017 City analysts expect the company’s earnings per share to grow by 153% and further earnings per share growth of 19% is pencilled-in for 2018. Based on these figures, the shares are trading at a 2017 forward P/E of 14.9 and support a dividend yield of 6.6%. 

Like BP, analysts are predicting strong earnings per share growth for Glaxo during 2017. Growth of 11% is pencilled-in for the year taking earnings to 112p, the highest level since 2012. Based on these estimates the shares are trading at a forward P/E of 14 and support a dividend yield of 5.2%. By 2017, Glaxo’s dividend payout will be covered 1.5 times by earnings per share.

One stock to avoid 

In comparison to Glaxo and BP, EasyJet (LSE: EZJ) looks to me to be a company to avoid during 2017. EasyJet’s advantage over its peers used to be the carrier’s low-cost model. However, over the past few years, this economic benefit has disappeared. 

As a result, City analysts are predicting a 28% decline in earnings per share for the fiscal year to 30 September 2017. These declines follow a 22% fall in earnings per share for 2016. For the year ending 30 September 2017, City analysts expect EasyJet report a pre-tax profit of £385m and earnings per share of 78p. For some comparison, two years ago EasyJet reported a record pre-tax profit of £686m and earnings per share of 139p. 

Even though the company’s dividend yield of 5.7%, is covered twice by earnings per share at present, this payout could come under pressure if earnings continue to decline. Shares in EasyJet currently trade at a forward P/E of 12.2, which looks appropriate considering the group’s rapidly declining profits. All in all, considering EasyJet’s flagging growth it may be best to avoid the company for the time being.

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended BP. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Artillery rocket system aimed to the sky and soldiers at sunset.
Investing Articles

£7,500 invested in BAE Systems shares 10 days ago is now worth…

Why have BAE Systems shares experienced a sudden double-digit pullback? And does this present a buying opportunity for my portfolio?

Read more »

Picture of an easyJet plane taking off.
Investing Articles

£10,000 invested in easyJet shares 4 weeks ago is now worth…

It's been a crazy month for easyJet shares. Here's what would have happened to an investor's £10,000 stake put to…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

Down 31%, is this a rare chance to buy Meta stock for my ISA cheaply?

After rising to near $800 in 2025, Meta stock has pulled back to around $550. Edward Sheldon looks at whether…

Read more »

Santa Clara offices of NVIDIA
Investing Articles

18% off its peak, is Nvidia stock now attractively priced?

Nvidia stock has given up almost a fifth of the price it commanded at its peak over the past year.…

Read more »

Aston Martin DBX - rear pic of trunk
Investing Articles

The Aston Martin share price destruction helps illustrate 5 common investing mistakes!

The Aston Martin share price has been a disaster for investors. Christopher Ruane highlights a handful of lessons we can…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Dividend Shares

How this stock market correction can help boost a second income by 25%

Jon Smith explains how rising dividend yields across some existing income shares can be seen as an opportunity to grow…

Read more »

Middle-aged Caucasian woman deep in thought while looking out of the window
Investing Articles

Considering a SIPP? Today’s market could provide an excellent opportunity to start

Mark Hartley breaks down the benefits of using a SIPP for retirement, and how current market conditions could offer a…

Read more »

Calendar showing the date of 5th April on desk in a house
Investing Articles

Looking for last-minute ISA ideas? Check out these UK stocks before April 3

Easter bank holidays mean the deadline to put cash into a Stocks and Shares ISA might be closer than UK…

Read more »